Compare Exelixis Inc. Common Stock (EXEL) vs IQVIA Holdings Inc. Common Stock (IQV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs IQVIA Holdings Inc. Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $59.77 (market cap $14.62B), while IQVIA Holdings Inc. Common Stock trades at $259.97 (market cap $42.61B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 2.9× Exelixis Inc. Common Stock's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, IQVIA Holdings Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and IQVIA Holdings Inc. Common Stock for 1 Days on average.
| EXEL | IQV | |
|---|---|---|
Market Cap | $14.62B | $42.61B |
Volume | 2,684,957 | 988,398 |
Sector | Health | Health |
52-Week High | $59.13 | $275.02 |
52-Week Low | $34.54 | $156.66 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $13.95B | $56.77B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About IQVIA Holdings Inc. Common Stock
IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →
